LEVALBUTEROL HCL IS A RELATIVELY SELECTIVE BETA2-ADRENERGIC RECEPTOR AGONIST. ACTIVATION OF BETA2-ADRENERGIC RECEPTORS ON AIRWAY SMOOTH MUSCLE LEADS TO THE ACTIVATION OF ADENYLCYCLASE AND TO AN INCREASE IN THE INTRACELLULAR CONCENTRATION OF CYCLIC-3', 5'-ADENOSINE MONOPHOSPHATE (CYCLIC AMP). THIS INCREASE IN CYCLIC AMP LEADS TO THE ACTIVATION OF PROTEIN KINASE A, WHICH INHIBITS THEPHOSPHORYLATION OF MYOSIN AND LOWERS INTRACELLULAR IONIC CALCIUM CONCENTRATIONS, RESULTING IN RELAXATION. LEVALBUTEROL RELAXES THE SMOOTH MUSCLES OF ALL AIRWAYS, FROM THE TRACHEA TO THE TERMINAL BRONCHIOLES. LEVALBUTEROL ACTS AS A FUNCTIONAL ANTAGONIST TO RELAX THE AIRWAY IRRESPECTIVE OF THE SPASMOGEN INVOLVED,THUS PROTECTING AGAINST ALL BRONCHOCONSTRICTOR CHALLENGES. INCREASED CYCLIC AMP CONCENTRATIONS ARE ALSO ASSOCIATED WITH THE INHIBITION OF RELEASE OF MEDIATORS FROM MAST CELLS IN THE AIRWAY.